These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8621408)

  • 1. Studies on inhibition of mu and delta opioid receptor binding by dithiothreitol and N-ethylmaleimide. His223 is critical for mu opioid receptor binding and inactivation by N-ethylmaleimide.
    Shahrestanifar M; Wang WW; Howells RD
    J Biol Chem; 1996 Mar; 271(10):5505-12. PubMed ID: 8621408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors.
    Wang WW; Shahrestanifar M; Jin J; Howells RD
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12436-40. PubMed ID: 8618916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification in the mu-opioid receptor of cysteine residues responsible for inactivation of ligand binding by thiol alkylating and reducing agents.
    Gaibelet G; Capeyrou R; Dietrich G; Emorine LJ
    FEBS Lett; 1997 May; 408(2):135-40. PubMed ID: 9187354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible affinity labeling of opioid receptors via disulfide bonding: discriminative labeling of mu and delta subtypes by chemically activated thiol-containing enkephalin analogs.
    Yasunaga T; Motoyama S; Nose T; Kodama H; Kondo M; Shimohigashi Y
    J Biochem; 1996 Aug; 120(2):459-65. PubMed ID: 8889834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the amino acid residues involved in selective agonist binding in the first extracellular loop of the delta- and mu-opioid receptors.
    Fukuda K; Terasako K; Kato S; Mori K
    FEBS Lett; 1995 Oct; 373(2):177-81. PubMed ID: 7589460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.
    Minami M; Nakagawa T; Seki T; Onogi T; Aoki Y; Katao Y; Katsumata S; Satoh M
    Mol Pharmacol; 1996 Nov; 50(5):1413-22. PubMed ID: 8913373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The conserved aspartate residue in the third putative transmembrane domain of the delta-opioid receptor is not the anionic counterpart for cationic opiate binding but is a constituent of the receptor binding site.
    Befort K; Tabbara L; Bausch S; Chavkin C; Evans C; Kieffer B
    Mol Pharmacol; 1996 Feb; 49(2):216-23. PubMed ID: 8632752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.
    Pogozheva ID; Lomize AL; Mosberg HI
    Biophys J; 1998 Aug; 75(2):612-34. PubMed ID: 9675164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profiles of selective non-peptidic delta opioid receptor ligands.
    Chaturvedi K; Jiang X; Christoffers KH; Chinen N; Bandari P; Raveglia LF; Ronzoni S; Dondio G; Howells RD
    Brain Res Mol Brain Res; 2000 Sep; 80(2):166-76. PubMed ID: 11038249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective interference of beta-arrestin 1 with kappa and delta but not mu opioid receptor/G protein coupling.
    Cheng ZJ; Yu QM; Wu YL; Ma L; Pei G
    J Biol Chem; 1998 Sep; 273(38):24328-33. PubMed ID: 9733719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the purified bovine mu opioid receptor by sulfhydryl reagents.
    Gioannini TL; Onoprishvili I; Hiller JM; Simon EJ
    Neurochem Res; 1999 Jan; 24(1):37-42. PubMed ID: 9973235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: I. Interaction with delta and mu sites.
    Castanas E; Bourhim N; Giraud P; Boudouresque F; Cantau P; Oliver C
    J Neurochem; 1985 Sep; 45(3):677-87. PubMed ID: 2993509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor.
    Kong H; Raynor K; Yano H; Takeda J; Bell GI; Reisine T
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8042-6. PubMed ID: 8058754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DAMGO, a mu-opioid receptor selective agonist, distinguishes between mu- and delta-opioid receptors around their first extracellular loops.
    Onogi T; Minami M; Katao Y; Nakagawa T; Aoki Y; Toya T; Katsumata S; Satoh M
    FEBS Lett; 1995 Jan; 357(1):93-7. PubMed ID: 8001688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14 alpha,14' beta-[Dithiobis[(2-oxo-2,1-ethanediyl)imino]]bis (7,8-dihydromorphinone) and 14 alpha,14' beta-[dithiobis[(2-oxo-2,1- ethanediyl)imino]]bis[7,8-dihydro-N-(cyclopropylmethyl)normorphinone]: chemistry and opioid binding properties.
    Archer S; Seyed-Mozaffari A; Jiang Q; Bidlack JM
    J Med Chem; 1994 May; 37(11):1578-85. PubMed ID: 7515442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14 beta-(Bromoacetamido)morphine irreversibly labels mu opioid receptors in rat brain membranes.
    Bidlack JM; Frey DK; Seyed-Mozaffari A; Archer S
    Biochemistry; 1989 May; 28(10):4333-9. PubMed ID: 2548575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The direct demonstration of binding of mu, delta and kappa agonists to digitonin-solubilized opioid receptors from bovine striatum.
    Crema G; Gioannini TL; Hiller JM; Simon EJ
    NIDA Res Monogr; 1986; 75():9-12. PubMed ID: 2829015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected cysteine residues in transmembrane domains of mu-opioid receptor are critical for effects of sulfhydryl reagents.
    Deng HB; Guang W; Wang JB
    J Pharmacol Exp Ther; 2000 Apr; 293(1):113-20. PubMed ID: 10734160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.